UNSPSC 51286504: Novobiocin

This classification denotes an antibiotic with the molecular formula C31H36N2O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17EC19951N, chemically known as novobiocin, sodium deriv. but more generally known as novobiocin, which bears US NIH Compound Identifier 4546. European Medicines Agency schedules Novobiocin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09385MIG.

The term NOVOBIOCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). NOVOBIOCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O1C(C(OC)C(OC(=O)N)C(O)C1OC1C(C2OC(O)C(NC(=O)C3CC(C/C=C(/C)C)C(O)CC3)C(=O)C2CC1)C)(C)C.

UNSPSC 51286504 Novobiocin is a Commodity code nominally identifying a specific antibiotic product, yet recent state and local solicitations under this code show substantial mismatch with the narrow product scope. The code appears in procurement for pharmaceutical supply contracts spanning generic multi-source drugs, over-the-counter products, naloxone and drug deactivation systems, and medical first-aid supplies for emergency response—categories far broader than novobiocin alone. State and local governments soliciting under this code include county health departments, state health and human services agencies, city fire departments, and multi-state cooperative purchasing alliances. The work involves establishing supply agreements with pharmaceutical manufacturers and wholesalers, managing direct-to-manufacturer prescription programs, procuring emergency medical consumables for fire and rescue operations, and supporting community health initiatives through competitive bidding and cooperative purchasing vehicles.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (response deadline July 26, 2023, though this date appears inconsistent with posting). The City of Tampa issued IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5% small local business enterprise bid discount available. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026 and awards effective July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program, indicating exploratory market research before formal solicitation. The code shows little recent activity specifically tied to novobiocin procurement and should be evaluated against actual commodity demand rather than the code's nominal product name.